But journalists shouldn’t rely on their sources to disclose real or potential conflicts. Just as medical writers have learned to pay attention to the nexus between Big Pharma and the research and drug trials conducted by academics, similar questions about the nexus between technology companies and the academics they support should become a standard part of a journalist’s tool kit when they turn to experts to sort through complicated matters of technology policy. Having a financial connection to a story doesn’t necessarily disqualify someone from commenting on it. But disclosing that connection is part of the journalist’s duty to his audience.
06:00 AM - December 3, 2010
The press should treat big tech companies like Big Pharma
‘See you on the other side’ - Meet Jessica Lum, a terminally ill 25-year-old who chose to spend what little time she had practicing journalism
#Realtalk: This is the best moment to be in journalism - The old stuff isn’t coming back, but that’s okay
Streams of consciousness - Millennials expect a steady diet of quick-hit, social-media-mediated bits and bytes. What does that mean for journalism?
Sticking with the truth - How ‘balanced’ coverage helped sustain the bogus claim that childhood vaccines can cause autism
An ink-stained stretch - Can Aaron Kushner save the Orange County Register—and the newspaper industry?
Matt Yglesias watched every Star Trek movie and every episode of every TV show in the franchise
The press and Congress are asking the wrong questions
A video that appears to show Toronto’s mayor smoking crack is being shopped around by a group of Somali men involved in the drug trade
The threat of even grander leaks
HD footage from the World Trade Center’s new spire
Who Owns What
A report from the Columbia University Graduate School of Journalism
Questions and exercises for journalism students.